Allogeneic hematopoietic stem cell transplant (HSCT) is a procedure with life-threatening complications that in turn has the potential to cure a significant proportion of patients with otherwise fatal diseases. Although improvements in patient and donor selection, conditioning strategies, timing, and infection management have increased the probability of long-term survival, patients undergoing HSCT still remain exposed to a number of transplant-related morbidities. Among these chronic graft versus host disease (cGVHD), a multi-organ syndrome involving tissue inflammation and fibrosis, may affect patient quality of life in several aspects, including sexual functioning. Erectile dysfunction (ED) a multidimensional organic, relational and psychological disturbance of the erectile response has long been reported to affect a significant proportion of HSCT patients. Although predictors for ED (e.g. cardiopathy, diabetes, hypertension, obesity, depression) have been largely established in the general population few studies have addressed any variables specifically associated to ED in HSCT patients.

Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience

Angelo Andreini;Nicola Zampieri;Claudio Costantini;Giovanni Malerba;Costanza Bruno;Gian Luca Salvagno;Giuseppe Francia;Michela Rimondini;Isacco Ferrarini;Giuseppe Lippi;Achille Ambrosetti;Fabio Benedetti;Cristina Tecchio
2018

Abstract

Allogeneic hematopoietic stem cell transplant (HSCT) is a procedure with life-threatening complications that in turn has the potential to cure a significant proportion of patients with otherwise fatal diseases. Although improvements in patient and donor selection, conditioning strategies, timing, and infection management have increased the probability of long-term survival, patients undergoing HSCT still remain exposed to a number of transplant-related morbidities. Among these chronic graft versus host disease (cGVHD), a multi-organ syndrome involving tissue inflammation and fibrosis, may affect patient quality of life in several aspects, including sexual functioning. Erectile dysfunction (ED) a multidimensional organic, relational and psychological disturbance of the erectile response has long been reported to affect a significant proportion of HSCT patients. Although predictors for ED (e.g. cardiopathy, diabetes, hypertension, obesity, depression) have been largely established in the general population few studies have addressed any variables specifically associated to ED in HSCT patients.
GVHD, allogeneic hematopoietic stem cell transplant, erectile dysfunction
File in questo prodotto:
File Dimensione Formato  
_system_appendPDF_proof_hi.pdf

non disponibili

Descrizione: Articolo principale
Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 451.75 kB
Formato Adobe PDF
451.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/974577
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact